- Receives Notification that SEC has Completed its Review
of DFHT’s Proxy Statement
- Stockholders are encouraged to submit their vote prior to the
special meeting
Deerfield Healthcare Technology Acquisitions Corp. (Nasdaq:
DFHT) (“DFHT” or the “Company”) today announced receipt of
notification from the U.S. Securities and Exchange Commission
(“SEC”) that the SEC has completed its review of DFHT’s proxy
statement relating to the proposed business combination (the
“Business Combination”) with CareMax Medical Group, LLC (“CareMax”)
and IMC Medical Group Holdings, LLC (“IMC”) and that it will
commence mailing the definitive proxy statement relating to the
special meeting of the Company’s stockholders (the “Special
Meeting”) to be held on Friday, June 4, 2021 at 11:00 a.m. The
definitive proxy statement is being mailed to the Company’s
stockholders of record as of the close of business on April 29,
2021 (the “Record Date”). Notice of the Special Meeting will be
mailed on or about May 14, 2021.
Your vote is important no matter how
many shares you own. You are encouraged to submit your vote as soon
as possible. If you hold your shares in an account at a
brokerage firm, bank or other similar agent, you may vote prior to
the meeting by using your voting control number and instructions
provided by your brokerage firm, bank or other similar agent. If
you are a stockholder of record, you may vote prior to the Special
Meeting by signing, dating and mailing your proxy card in the
return envelope provided with your proxy material. If you are a
stockholder of record as of the record date and would like to
attend and vote at the Special Meeting, you will need to follow the
instructions applicable to them provided in the definitive proxy
statement.
DFHT expects to close the proposed Business Combination as soon
as practicable following the Special Meeting.
Additional Information and Where to Find It
DFHT has filed a definitive proxy statement in connection with
the Business Combination and other matters and will mail the
definitive proxy statement to its stockholders as of the Record
Date established for voting on the Business Combination. DFHT’s
stockholders and other interested persons are advised to read the
definitive proxy statement, in connection with DFHT’s solicitation
of proxies for its Special Meeting of stockholders to be held to
approve, among other things, the Business Combination, because
these documents contain important information about DFHT, CareMax,
IMC and the Business Combination. DFHT’s stockholders may also
obtain a copy of the definitive proxy statement, as well as other
documents filed with the SEC by DFHT, without charge, at the SEC’s
website located at www.sec.gov or by directing a request to:
Deerfield Healthcare Technology Acquisitions Corp., 780 Third
Avenue, New York, NY 10017, Attention: Corporate Secretary, or by
calling (212) 551-1600. The information contained on, or that may
be accessed through, the websites referenced in this press release
is not incorporated by reference into, and is not a part of, this
press release.
About Deerfield Healthcare Technology Healthcare Acquisitions
Corp.
Deerfield Healthcare Technology Acquisitions Corp. is a blank
check company whose business purpose is to effect a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses. The
Company’s sponsor is an affiliate of Deerfield Management Company,
L.P., an investment firm focused exclusively on the healthcare
industry, and Richard Barasch, a veteran healthcare public company
executive and investor.
About CareMax Inc.
CareMax, comprised of the existing CareMax, IMC, and
CareOptimize, is a technology-enabled care platform providing
value-based care and chronic disease management to Seniors.
Collectively, the Company operates 26 wholly owned medical centers
that offer a comprehensive suite of healthcare and social services,
and a proprietary software and services platform that provides
data, analytics, and rules-based decision tools/workflows for
physicians across the United States.
Forward-Looking Statements
This Current Report includes certain statements that are not
historical facts but are forward-looking statements for purposes of
the safe harbor provisions under the United States Private
Securities Litigation Reform Act of 1995. Forward-looking
statements generally are accompanied by words such as “believe,”
“may,” “will,” “estimate,” “continue,” “anticipate,” “intend,”
“expect,” “should,” “would,” “plan,” “predict,” “potential,”
“seem,” “seek,” “future,” “outlook,” and similar expressions that
predict or indicate future events or trends or that are not
statements of historical matters. These forward-looking statements
include, but are not limited to, statements regarding projections,
estimates and forecasts of revenue and other financial and
performance metrics and projections of market opportunity and
expectations, the expectation that the combined company’s Class A
common stock will be listed on Nasdaq, and the anticipated closing
date of the proposed Business Combination. These statements are
based on various assumptions and on the current expectations of
DFHT, CareMax management and IMC management and are not predictions
of actual performance. These forward-looking statements are
provided for illustrative purposes only and are not intended to
serve as, and must not be relied on by any investor as, a
guarantee, an assurance, a prediction or a definitive statement of
fact or probability. Actual events and circumstances are difficult
or impossible to predict and will differ from assumptions. Many
actual events and circumstances are beyond the control of DFHT,
CareMax and IMC. These forward-looking statements are subject to a
number of risks and uncertainties, including the outcome of
judicial and administrative proceedings to which CareMax or IMC may
become a party or governmental investigations to which CareMax or
IMC may become subject that could interrupt or limit CareMax’s or
IMC’s operations, result in adverse judgments, settlements or fines
and create negative publicity; changes in CareMax’s or IMC’s
clients’ preferences, prospects and the competitive conditions
prevailing in the healthcare sector; the inability of the parties
to successfully or timely consummate the proposed Business
Combination, including the risk that any required regulatory
approvals are not obtained, are delayed or are subject to
unanticipated conditions that could adversely affect the combined
company or the expected benefits of the proposed Business
Combination or that the approval of the stockholders of DFHT and/or
the equity holders of CareMax or IMC for the proposed Business
Combination is not obtained; failure to realize the anticipated
benefits of the proposed Business Combination, including as a
result of a delay in consummating the proposed Business Combination
or a delay or difficulty in integrating the businesses of DFHT,
CareMax and IMC; the amount of redemption requests made by DFHT’s
stockholders; those factors discussed in DFHT’s proxy statement
filed relating to the Business Combination, including those under
“Risk Factors” therein, and other documents of DFHT filed with the
SEC. If the risks materialize or assumptions prove incorrect,
actual results could differ materially from the results implied by
these forward-looking statements. There may be additional risks
that neither DFHT, CareMax nor IMC presently know or that DFHT,
CareMax and IMC currently believe are immaterial that could also
cause actual results to differ from those contained in the
forward-looking statements. In addition, forward-looking statements
reflect DFHT’s, CareMax’s and IMC’s expectations, plans or
forecasts of future events and views as of the date of this Current
Report. DFHT, CareMax and IMC anticipate that subsequent events and
developments will cause DFHT’s, CareMax’s and IMC’s assessments to
change. However, while DFHT, CareMax and IMC may elect to update
these forward-looking statements at some point in the future, DFHT,
CareMax and IMC specifically disclaim any obligation to do so.
These forward-looking statements should not be relied upon as
representing DFHT’s, CareMax’s and IMC’s assessments as of any date
subsequent to the date of this Current Report. Accordingly, undue
reliance should not be placed upon the forward-looking
statements.
Participants in the Solicitation
DFHT and its directors and executive officers may be considered
participants in the solicitation of proxies with respect to the
proposed Business Combination. Information about the directors and
executive officers of DFHT and a description of their interests in
DFHT are set forth in the definitive proxy statement relating to
the proposed Business Combination, which can be obtained free of
charge from the sources indicated above.
Non-Solicitation
This press release does not constitute a solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the proposed Business Combination. This press release
also does not constitute an offer to sell or the solicitation of an
offer to buy any securities, nor will there be any sale of
securities in any states or jurisdictions in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction.
No offering of securities will be made except by means of a
prospectus meeting the requirements of section 10 of the Securities
Act of 1933, as amended, or an exemption therefrom.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210514005135/en/
DFHT Chris Wolfe chris.wolfe@dfhealthcaretech.com
DFHT Investor Relations The Equity Group Inc. Devin
Sullivan Senior Vice President dsullivan@equityny.com (212) 836-9608
Deerfield Healthcare Tec... (NASDAQ:DFHT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Deerfield Healthcare Tec... (NASDAQ:DFHT)
Historical Stock Chart
From Nov 2023 to Nov 2024
